ABOUT KNOPP BIOSCIENCES
Discovering, developing, and delivering breakthrough medicines.
The vision of Knopp Biosciences is to change the course of human health. We target diseases imposing high costs on the healthcare system, with patient populations clearly identifiable using validated biomarkers or genetic testing.
Knopp is also committed to expanding the drug discovery and development industry in Western Pennsylvania. The Pittsburgh area is home to some of the nation's most significant and well-funded research institutions, creating a favorable environment for the biopharma industry. Knopp plays an important role in expanding the region’s capabilities and reputation as a premier location for bioscience commercialization.
The mission of Knopp Biosciences is to discover, develop, and deliver breakthrough medicines for devastating diseases and to improve global access to health care. We target diseases imposing high costs on the healthcare system, with patient populations clearly identifiable using validated biomarkers or genetic testing.
We predicate our work on the value of collaboration, the fundamentals of quality and safety, and an unwavering commitment to our patients, partners, shareholders, community, and colleagues.
We are driven by our unwavering commitment to patients, our partners, and the bioscience community to revolutionize medicine.
Our research has led to an investigational compound in clinical development for immunological disorders, as well as discovery platforms directed to small molecule mediators of epilepsy and neuropathic pain.
We bring unmatched energy and a new level of collaboration with practitioners, patient communities, and business partners, allowing us to bridge the distance from the laboratory to the bedside. We understand that every day counts for patients and families with devastating diseases.